Concepedia

Mark Holck

MH

17

Publications

639

Citations

14

H-Index

1978

Active since

Affiliations

Roche (Switzerland)(Current)

Mark Holck is an author at Roche (Switzerland) specializing in medicine, pharmacology, and physiology.

Top concepts

MedicinePharmacologyPhysiologyPharmacotherapyCardiologyElectrophysiologyCardiovascular PhysiologyVascular BiologyMolecular PharmacologyMolecular Physiology

Publications per year

1978–1989

17

Publications

17

In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic Action

Wolfgang Osterrieder, Mark Holck · Journal of Cardiovascular Pharmacology · 1989 · 101 citations

In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic Action

Wolfgang Osterrieder, Mark Holck · Journal of Cardiovascular Pharmacology · 1989 · 90 citations

Cardiovascular Pharmacology, Potent Vasodilator, Vitro Pharmacologic Profile +20

Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens.

Mark Holck, Bernard H. Marks · Journal of Pharmacology and Experimental Therapeutics · 1978 · 82 citations

Characterization of [3H]nifedipine binding sites in rabbit myocardium

Mark Holck, Sébastien Thorens, Guenther Haeusler · European Journal of Pharmacology · 1982 · 73 citations

Molecular Pharmacology, Cardiac Muscle, Molecular Physiology +9

Differential Interactions of Clonidine and Methoxamine with the Postsynaptic α-Adrenoceptor of Rabbit Main Pulmonary Artery

Mark Holck, C. Jones, G. Haeusler · Journal of Cardiovascular Pharmacology · 1983 · 62 citations

Molecular Pharmacology, Pulmonary Arterial Hypertension, Pulmonary Circulation +15

Rows per page

1–5 of 17